About Agios (AGIO)
Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
- USD31.50
- USD32.74
- USD31.50
- USD35.50
- 8.40%
- 27M
- 121.17k
- 652.56k
- 1.8B
- 19.80
- 42.50%
Stock News
1 hour ago
ICE to Provide OTC Derivatives Pricing and Risk Management Solution to Multinational Mining and Metallurgy Company Eramet S.A.
Yahoo
1 hour ago
These 3 Dividend Payers Are Forever Stocks, Even if the Market Crumbles
Yahoo
1 hour ago
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Yahoo
2 hours ago
Immutep Quarterly Activities Report Q3 FY24
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
